Search

Your search keyword '"Pardi, Norbert"' showing total 397 results

Search Constraints

Start Over You searched for: Author "Pardi, Norbert" Remove constraint Author: "Pardi, Norbert"
397 results on '"Pardi, Norbert"'

Search Results

6. Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination

7. Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals

10. mRNA-LNP vaccine-induced CD8+ T cells protect mice from lethal SARS-CoV-2 infection in the absence of specific antibodies

14. Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody induction

16. VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosis

18. Messenger RNA-Based Vaccines Against Infectious Diseases

20. Enabling non-viral DNA delivery using lipid nanoparticles co-loaded with endogenous anti-inflammatory lipids

22. Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine

24. Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE)

27. Enhancing prime editor activity by directed protein evolution in yeast

28. Single cell phototransfection of mRNAs encoding SARS-CoV2 spike and nucleocapsid into human astrocytes results in RNA dependent translation interference

30. Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood–brain barrier

31. In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels

32. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses

33. Treatment of a genetic liver disease in mice through transient prime editor expression

35. Broadly neutralizing antibody induction by non-stabilized SARS-CoV-2 Spike mRNA vaccination in nonhuman primates

38. Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates

42. Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates

43. Anti-PfGARP activates programmed cell death of parasites and reduces severe malaria

44. PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake

46. Expression and purification of the receptor‐binding domain of SARS‐CoV‐2 spike protein in mammalian cells for immunological assays.

50. Trivalent nucleoside-modified mRNA vaccine yields durable memory B cell protection against genital herpes in preclinical models

Catalog

Books, media, physical & digital resources